GlassScriptPhysician profile
Dena R Jenkins
NPI 1124666284
$4,132.59
in general payments reported to CMS, 2019-2025
16 companies · $1,751 in 2025
The $1,751 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.49 · 2022: $133 · 2023: $271 · 2024: $1,936 · 2025: $1,751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,121 · Food and Beverage: $1,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,120.98 |
| Food and Beverage | $1,836.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $3,299.43 | 2024-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $330.58 | 2023-2025 | Gemtesa |
| Antares Pharma, INC. | $113.03 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Urovant Sciences INC | $57.12 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $53.02 | 2023-2025 | |
| Olympus America INC. | $50.91 | 2023-2025 | Itind System, Soltive |
| Convatec INC. | $44.77 | 2025 | |
| Ferring Pharmaceuticals INC. | $32.62 | 2024-2025 | Adstiladrin |
| Coloplast Corp | $29.69 | 2021-2022 | |
| 180 Medical, INC. | $25.57 | 2022-2023 | Gentlecath Glide |
| Immunitybio, INC. | $18.73 | 2025 | |
| Boston Scientific Corporation | $17.28 | 2025 | Bulkamid |
| Halozyme INC | $16.06 | 2023 | |
| Novo Nordisk INC | $15.91 | 2021 | |
| Valencia Technologies Corporation | $14.59 | 2024 | Ecoin Device Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $13.28 | 2023 | Illuccix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dena Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.